Log in
Enquire now
‌

US Patent 11273442 Programmable nuclease compositions and methods of use thereof

Patent 11273442 was granted and assigned to Mammoth Biosciences on March, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Mammoth Biosciences
Mammoth Biosciences
0
Current Assignee
Mammoth Biosciences
Mammoth Biosciences
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
112734420
Patent Inventor Names
Maria-Nefeli Tsaloglou0
Pedro Patrick Draper Galarza0
Xin Miao0
Andrew Besancon Lane0
Ashley Tehranchi0
Clare Louise Fasching0
James Paul Broughton0
Janice Sha Chen0
...
Date of Patent
March 15, 2022
0
Patent Application Number
170375920
Date Filed
September 29, 2020
0
Patent Citations
‌
US Patent 10337051 Methods and compositions for detecting a target RNA
‌
US Patent 10494664 Methods and compositions for detecting a target RNA
‌
US Patent 10648020 CRISPR enzymes and systems
‌
US Patent 10570415 RNA-guided nucleic acid modifying enzymes and methods of use thereof
‌
US Patent 10113179 Compositions and methods for modifying genomes
‌
US Patent 10253365 Type V CRISPR/Cas effector proteins for cleaving ssDNAs and detecting target DNAs
‌
US Patent 10266886 CRISPR effector system based diagnostics
‌
US Patent 10266887 CRISPR effector system based diagnostics
...
Patent Citations Received
‌
US Patent 12129468 Signal boost cascade assay
0
‌
US Patent 11821025 Compositions of matter for detection assays
0
‌
US Patent 11859182 Tuning cascade assay kinetics via molecular design
0
‌
US Patent 11884921 Signal boost cascade assay
0
‌
US Patent 11884922 Tuning cascade assay kinetics via molecular design
0
‌
US Patent 11946052 Tuning cascade assay kinetics via molecular design
0
‌
US Patent 11965205 Detection of nucleic acid and non-nucleic acid target molecules
0
‌
US Patent 11970730 Compositions of matter for detection assays
0
...
Patent Primary Examiner
‌
David C Thomas
0
CPC Code
‌
C12N 9/22
0
‌
B01L 3/502715
0
‌
C12Q 1/6816
0
‌
C12N 2310/20
0
‌
C12N 15/113
0

Described herein are devices, systems, fluidic devices, kits, and methods for detection of target nucleic acids associated with diseases, cancers, genetic disorders, a genotype, a phenotype, or ancestral origin. The devices, systems, fluidic devices, kits, and methods may comprise reagents of a guide nucleic acid targeting a target nucleic acid, a programmable nuclease, and a single stranded detector nucleic acid with a detection moiety. The target nucleic acid of interest may be indicative of a disease, and the disease may be communicable diseases, or of a cancer or genetic disorder. The target nucleic acid of interest may be indicative of a genotype, a phenotype, or ancestral origin.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11273442 Programmable nuclease compositions and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.